The role of nitric oxide in multiple sclerosis

Journal of Molecular Medicine

Volumn 75, Issue 3, 1997, Pages 174-186

  Parkinson, John F ^a   Mitrovic, Branislava ^a   Merrill, Jean E ^a  

^a BAYER AG   (Germany)

Author keywords

Astrocytes; Demyelination; Microglia; Multiple sclerosis; Nitric oxide

Indexed keywords

AMINOGUANIDINE; CYTOKINE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ASTROCYTE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; ENCEPHALITIS; GLIA CELL; HUMAN; IMMUNE SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MULTIPLE SCLEROSIS; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

ANIMALS; BRAIN; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; NEUROGLIA; NITRIC OXIDE;

EID: 0030948467     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050102     Document Type: Review

References (149)

1. Murphy S, Grzybicki DM, Simmons ML (1995) Glial cells as nitric oxide sources and targets. In: Vincent S (ed) Nitric oxide in the nervous system. Academic. San Diego, pp 164-190
2. Bukrinsky MI, Nottet HSLM, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, Lipton SA, Gendelman HE (1995) Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 181:735-745
3. De Maria R, Cifone MG, Trotta R, Rippo MR, Festuccia C, Santoni A, Testi R (1994) Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 180:1999-2004
4. Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Becherel P, Debre P, Moncada S, Djavad-Mossalayi M (1995) The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcεRII/CD23 surface antigen. Proc Natl Acad Sci USA 92: 7804-7808
5. Merrill JE, Graves MC, Mulder DG (1992) Autoimmune disease and the nervous system: biochemical, molecular, and clinical update. West J Med 156:639-646
6. Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612
7. Hofman FM, von Hanwehr RI, Dinarello CA, Mizel SB, Hinton D, Merrill JE (1986) Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J Immunol 136:3239-3245
8. Merrill JE, Strom SR, Ellison GW, Myers LW (1989) In vitro study of mediators of inflammation in multiple sclerosis. J Clin Immunol 9:84-96
9. Hauser SL, Doolittle DH, Lincoln R, Brown RH, Dinarello CA (1990) Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurol 40:1735-1739
10. Link J, Soderstrom M, Olsson T, Hojeberg B, Ljungdahl A, Link H (1994) Increased transforming growth factor-β, interleukin-4, and interferon-γ in multiple sclerosis. Ann Neurol 36:379-386
11. Chofflon M, Juillard C, Juillard P, Gauthier G, Grau GE (1992) Tumor necrosis factor a production as a possible predictor of relapse in patients with multiple sclerosis. Eur Cytokine Netw 316:523-531
12. Huberman M, Shalit F, Roth-Deri I, Gutman B, Kott E, Sredni B (1993) Decreased IL-3 production by peripheral blood mononuclear cells in patients with multiple sclerosis. J Neurol Sci 118:79-82
13. Beck J, Rondot P, Catinot L, Falcoff E, Kirchner H, Wietzerbin J (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 78:318-326
14. The IFN-beta Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomised, double-blind, placebo-controlled trial. Neurol 43:655-661
15. Ransohoff RM, Devajyothi C, Estes ML, Babcock G, Rudick RA (1991) Interferon-β specifically inhibits interferon-γ-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line. J Neuroimmunol 33:103-112
16. Merrill JE, Kono DH, Clayton J, Ando DG, Hinton DR, Hofman FM (1992) Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci USA 89:574-578
17. Kennedy MK, Torrance DS, Picha KS, Mohler KM (1992) Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 149:2496-2505
18. Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula SJ, Clark RB (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172: 1193-1200
19. Huitinga I, van Rooijen N, de Groot CJA, Uitdehaag BMJ, Dijkstra CD (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172:1025-1034
20. Willenborg DO, Fordham SA, Cowden WB, Ramshaw IA (1995) Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand J Immunol 41:31-41
21. Cash E, Minty A, Ferrara P, Caput D, Fradelizi D, Rott O (1994) Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol 153:4258-4267
22. Rott O, Fleischer B, Cash E (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 24:1434-1440
23. Khoury SJ, Hancock WW, Weiner HL (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulution transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176:1355-1364
24. Koka P, He K, Zack JA, Kitchen S, Peacock W, Fried I, Tran T, Yashar SS, Merrill JE (1995) Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor α, and nitric oxide in glial cultures from fetal, neonatal, and adult human brain. J Exp Med 182:941-952
25. Reiling N, Ulmer AJ, Duchrow M, Ernst M, Flad H-D, Hauschildt S (1994) Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol 24:1941-1944
26. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151:2132-2141
27. Dileepan KN, Page JC, Li Y, Stechschulte DJ (1995) Direct activation of murine peritoneal macrophages for nitric oxide production and tumor cell killing by interferon-γ. J Interfer Cyto Res 15:387-394
28. Lee SC, Dickson DW, Liu W, Brosnan CF (1993) Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon γ. J Neuroimmunol 46:19-24
29. Stevenson MM, Tam MF, Wolf SF, Sher A (1995) IL-12 induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J Immunol 155:2545-2556
30. Rockett KA, Awburn BMM, Aggarwal BB, Cowden WB, Clark IA (1992) In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria. Infect Immun 60:3725-3730
31. Chiang C-S, Stalder A, Samimi A, Campbell IL (1994) Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev Neurosci 16:212-221
32. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T (1995) Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80:353-361
33. MacMicking JD, Nathan C, Hom G, Chartain N, Fletcher DS, Trumbauer M, Stevens K, Xie Q-W, Sokol K, Hutchinson N, Chen HG, Mudgett JS (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650
34. Fast DJ, Lynch RC, Leu RW (1993) Interferon-gamma, but not interferon-alpha beta, synergizes with tumor necrosis factor-alpha and lipid A in the induction of nitric oxide production by murine L929 cells. J Interferon Res 13:271-277
35. Fujihara M, Ito N, Pace JL, Watanabe Y, Russell SW, Suzuki T (1994) Role of endogenous interferon-beta in lipopolysaccharide-triggered activation of the inducible nitric oxide synthase gene in the mouse macrophage cell line, J774. J Biol Chem 129:12773-12778
36. Zhang X, Alley EW, Russell SW, Morrison DC (1994) Necessity and sufficiency of beta interferon for nitric oxide production in mouse peritoneal macrophages. Infect Immun 62: 33-40
37. Doyle AG, Herbein G, Montener LJ, Minty AJ, Caput D, Ferrara P, Gordon S (1994) Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-γ. Eur J Immunol 24:1441-1445
38. Ding A, Nathan C. F. Graycar J Derynck R Stuehr D. J Srimal S (1990) Macrophage deactivating factor and transforming growth factors-β1, -β2,-β3 inhibit induction of macrophage nitrogen oxide synthesis by IFNγ. J Immunol 145: 940-944
39. Vodovotz Y, Kwon NS, Pospischil M, Manning J, Paik J, Nathan C (1994) Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-γ and bacterial lipopolysacchardide. J Immunol 152:4110-4118
40. Vodovotz Y, Bogdan C, Paik J, Xie Q-W, Nathan C (1993) Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J Exp Med 178: 605-613
41. Boutard V, Havouis R, Fouqueray B, Philippe C, Moulinoux J-P, Baud L (1995) Transforming growth factor-β stimulates arginase activity in macrophages. J Immunol 155:2077-2084
42. Hausmann EH, Hao SY, Pace JL, Parmely MJ (1994) Transforming growth factor beta 1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages. Infect Immun 62:3625-3632
43. Alleva DG, Burger CJ, Elgert KD (1994) Tumor-induced regulation of suppressor macrophage nitric oxide and TNFD-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2. J Immunol 153:1674-1686
44. Kanno K, Hirata Y, Imai T, Iwashina M, Marumo F (1994) Regulation of inducible nitric oxide synthase gene by interleukin-1 beta in rat vascular endothelial cells. Am J Physiol 267:H2318-2324
45. Chesrown SE, Monnier J, Visner G, Nick HS (1994) Regulation of inducible nitric oxide synthase mRNA levels by LPS, IFNγ, TGFβ, and IL-10 in murine macrophage cell lines und rut peritoneal macrophages. Biochem Biophys Res Commun 200:126-134
46. Gazzinelli RT, Oswald IP, James SL, Sher A (1992) IL-10 inhibits parasite killing and nitrogen oxide production by IFNγ-activated macrophages. J Immunol 148:1792-1796
47. Romani L, Puccetti P, Menacci A, Cenci E, Spaccapelo R, Tonnetti L, Grohmann U, Bistoni F (1994) Neutralization of IL-10 upregulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 152:3514-3521
48. Oswald IP, Gazzinelli RT, Sher A, James SL (1992) IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 148:3578-3582
49. Cunha FQ, Moncada S, Liew FY (1992) Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem Biophys Res Commun 182:1155-1159
50. Appelberg R (1995) Opposing effects of interleukin-10 on mouse macrophage functions. Scand J Immunol 41:539-544
51. Chao CC, Molitor TW, Hu S (1993) Neuroprotective role of IL-4 against activated microglia. J Immunol 151:1473-1481
52. Bogdan C, Vodovotz Y, Paik J, Xie Q-W, Nathan C (1994) Mechanisms of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J Leuko Biol 55:227-233
53. Cenci E, Romani L, Mencacci A, Spaccapelo R, Schiaffella E, Puccetti P, Bistoni F (1993) Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 23:1034-1038
54. Liew FY, Li Y, Severn A, Millott S, Schmidt J, Salter M, Moncada S (1991) A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur J Immunol 21:2489-2494
55. Al Ramadi BK, Meissler JJ, Huang D, Eisenstein TK (1992) Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur J Immunol 22:2249-2254
56. Sands WA, Bulut V, Severn A, Xu D, Liew FY (1994) Inhibition of nitric oxide synthase by interleukin-4 may involve inhibiting the activation of protein kinase C e. Eur J Immunol 24:2345-2350
57. Schneemann M, Schoedon G, Frei K, Schaffner A (1993) Immunovascular communication: activation and deactivation of murine endothelial cell nitric oxide synthase by cytokines. Immunol Lett 35:159-162
58. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A (1992) The microbicidal activity activity of interferon-γ-treated macrophages against Trypansoma cruzi involves L-arginine-dependent nitrogen-oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β. Eur J Immunol 22:2501-2512
59. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822
60. 2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun 206:667-673
61. 2. J Exp Med 180:2365-2370
62. Mautino G, Paul-Eugene N, Chanez P, Vignola AM, Kolb JP, Bousquet J, Dugas B (1994) Heterogeneous spontaneous and interleukin-4-induced nitric oxide production by human monocytes. J Leukoc Biol 56:15-20
63. Pierre Kolb JP, Paul-Eugene N, Damais C, Yamaoka K, Drapier JC, Dugas B (1994) Interleukin-4 stimulates cGMP production by IFN-γ-activated human monocytes. J Biol Chem 269:9811-9816
64. Paul-Eugene N, Kolb JP, Damais C, Dugas B (1994) Heterogeneous nitrite production by IL-4 stimulated human monocytes and peripheral blood mononucleur cells. Immunol Lett 42:31-34
65. Dugas B, Paul-Eugene N, Yamaoka K, Amirand C, Damais C, Kolb JP (1995) IL-4 induces cAMP and cGMP in human monocytic cells. Med Inflamm 4:298-305
66. Tian L, Lawrence DA (1995) Lead induces nitric oxide production in vitro by murine spenic macrophages. Toxicol Appl Pharmacol 132:156-163
67. Paul-Eugene N, Pene J, Bousquet J, Dugas B (1995) Role of cyclic nucleotides and nitric oxide in blood mononucleur cell IgE production stimulated by IL-4. Cytokine 7:64-69
68. Paul-Eugene N Kolb J-P, Damais C, Yamaoka K, Dugas B (1994) Regulatory role of nitric oxide in the IL-4-Induced IgE production by normal human peripheral blood mononuclear cells. Lymphokine Cytokine Res 13:287-293
69. Becherel PA, Mossalayi MD, Le-Goff L, Ouuaz F, Dugas B, Guillosson JJ, Debre P, Arock M (1994) IgE-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes: the role of cAMP and nitric oxide. Cell Molec Biol 40:283-290
70. Alonso A, Carvalho J, Alonso-Torre SR, Nunez L, Bosca L, Crespo M, S (1995) Nitric oxide synthesis in rat peritoneal macrophages is induced by IgE/DNP complexes and cyclic AMP analogues. Evidence in favor of a common signaling mechanism. J Immunol 154:6475-6483
71. Feinstein DL, Galea E, Reis DJ (1993) Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures J Neurochem 60:1945-1948
72. Bulut V, Severn A, Liew FY (1993) Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP. Biochem Biophys Res Comm 195:1134-1138
73. Marotta P, Sautebin L, DiRosa M (1992) Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol 107:640-641
74. Kozaki K, Egawa H, Bernudes L, Feduska NJ, So S, Esquivel CO (1993) Pentoxifylline inhibits production of superoxide anion and tumor necrosis factor by kupffer cells in rat liver preservation. Transplant Proc 25:3025-3026
75. Takahashi GW, Montgomery RB, Stahl WL, Crittenden CA, Valentine MA, Thorning DR, Andrews F, Lilly MB (1994) Pentoxifylline inhibits tumor necrosis factor-a mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells. Int J Immunopharmacol 16:723-736
76. Biswas DK, Dezube BJ, Ahlers CM, Pardee AB (1993) Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-κB action. J AIDS 6:778-786
77. Sommer N, Loschmann PA, Northoff GH, Weller M, Steinbrecher A, Steinbach JP, Lichtenfels R, Meyermann R, Riethmuller A, Fontana A, Dichgans J, Martin R (1995) The anti-depressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med 1:244-248
78. Genain CP, Roberts T, Davis RL, Nguyen M-H, Uccelli A, Faulds D, Li Y, Hedgpeth J, Hauser SL (1995) Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc Natl Acad Sci USA 92:3601-3605
79. Rott O, Cash E, Fleischer B (1993) Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type1 - but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur J Immunol 23:1745-1751
80. Lander HM, Sehajpal PK, Levine DM, Novogordsky A (1993) Activation of human peripheral blood mononuclear cells by nitric-oxide generating compounds. J Immunol 150: 1509-1516
81. Lander HM, Sehajpal PK, Novogrodsky A (1993) Nitric oxide signaling: a possible role for G proteins. J Immunol 151: 7182-7187
82. Magrinat G, Mason SN, Shami PJ, Weinberg JB (1992) Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood 80:1880-1884
83. Marcinkiewicz J, Grabowska A, Chain B (1995) Nitric oxide upregulates the release of inflammatory mediators by mouse macrophages. Eur J Immunol 25:947-951
84. Andrew PJ, Harant H, Lindley IJD (1995) Nitric oxide regulates 1L-8 expression in melanoma cells at the transcriptional level. Biochem Biophys Res Commun 214:949-956
85. Eigler A, Sinha B, Endres S (1993) Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem Biophys Res Comm 196:494-501
86. Fulle H-J, Endres S, Sinha B, Stoll D, Weber PC, Gerzer R (1991) Effects of SIN-1 on cytokine synthesis in human mononuclear cells. J Cardiovasc Pharmacol 17:S113-S116
87. Peng H-B, Libby P, Liao JK (1995) Induction and stabilisation of IκBa by nitric oxide mediates inhibition of NF-κB. J Biol Chem 270:14214-14219
88. De Caterina R, Libby P, Peng H-B, Thannickal VJ, Rajavashisth TB, Gimbrone MA, Shin WS, Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68
89. Wei X-Q, Charles IG, Smith A, Ure J, Feng G-J, Huang F-P, Xu D, Muller W, Moncada S, Liew FY (1995) Altered immune responses in mice lacking nitric oxide synthase. Nature 375:408-410
90. Stewart AG, Phan LH, Grigoriadis G (1994) Physiological and pathophysiological roles of nitric oxide. Microsurg 15: 693-702
91. Van der Meide PH, De Labie MCDC, Botman CAD, Aten J, Weening JJ (1995) Nitric oxide suppresses IFN- g production in the spleen of mercuric chloride-exposed brown Norway rats. Cell Immunol 161:195-206
92. Blanco FJ, Lotz M (1995) IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res 218: 319-325
93. Fehsel K, Kroncke K-D, Meyer KL, Huber H, Wahn V, Kolb-Bachofen V (1995) Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 155:2858-2865
94. Nathan C (1995) Natural resistance and nitric oxide. Cell 82: 873-876
95. Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4654
96. Sicher SC, Vazquez MA, Lu CY (1994) Inhibition of macrophage Ia expression by nitric oxide. J Immunol 153: 1293-1300
97. MacMicking JD, Willenborg DO, Weidemann MJ, Rockett KA, Cowden WB (1992) Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalitis: enhancement by the soluble products of encephalitogenic T cells. J Exp Med 176:303-307
98. Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B (1993) In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA 90:3024-3027
99. Zheng YM, Schäfer MK-H, Weihe E, Sheng H, Corisdeo S, Fu ZF, Koprowski H, Dietzschold B (1993) Severity of neurologic signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase. J Virol 67:5786-5791
100. Lin RF, Lin T-S, Tilton RG, Cross AH (1993) Nitric oxide localized to spinal cords of mice with experimental allergic encephalitis: an electron paramagnetic resonance study. J Exp Med 178:643-648
101. Hooper DC, Ohnishi ST, Kean R, Numagami Y, Dietzschold B, Koprowski H (1995) Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc Natl Acad Sci USA 92:5312-5316
102. Kubrina LN, Caldwell WS, Mordvintcev PI, Malenkova IV, Vanin AF (1992) EPR evidence for nitric oxide production from guanidino nitrogens of L-arginine in animal tissues in vivo. Biochem Biophys Acta 1099:233-237
103. Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL, Tilton RG (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalitis in SJL mice. J Clin Invest 93:2684-2690
104. Zielasek J, Jung S, Gold R, Liew FY, Toyka KV, Hartung HP (1995) Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalitis. J Neuroimmunol 58:81-88.
105. Ruuls SR, Van Der Linden K, Sontrop I, Huitinga Dijkstra CD (1996) Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors
106. Buster BL, Weintrob AC, Townsend GC, Scheid WM (1995) Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect Immun 63: 3835-3839
107. Boje KMK (1995) Inhibition of nitric oxide synthase partially attenuates alterations in the blood-cerebrospinal fluid barrier during experimental memningitis in rats Eur J Pharmacol 272:297-300
108. Karpus WJ, Lukacs NW, McRAe BL, Strieter RM, Kunkel SL, Miller SD (1995) An important role for the chemokine macrophage inflammatory protein-1a in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalitis. J Immunol 155:5003-5010
109. Merrill JE, Benveniste EN (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 19:331-338
110. Mitrovic B, Ignarro JL, Montestruque S, Smoll A, Merrill JE (1994) Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neurosci 61:575-585
111. Mitrovic B, Ignarro JL, Vinters HV, Akers M-A, Schmid I, Uittenbogaart C, Merril JE (1995) Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neurosci 65:531-539
112. Dugas B, Djavad-Mossalayi M, Damais C, Chantal Kolb JP (1995) Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol Today 16:574-580
113. Colasanti M, Di Pucchio T, Perschini T, Sogos V, Preste M, Lauro G (1995) Inhibition of inducible nitric oxide synthase mRNA expression by basic fibroblast growth factor in human microglial cells. Neurosci Lett 195:45-48
114. St. Pierre BA, Granger DA, Wong J, Merrill JE (1995) A study on tumor necrosis factor, tumor necrosis factor receptors, and nitric oxide in human fetal glial cultures. Adv Pharmacol 34:415-438
115. Mitrovic B, St. Pierre BA, Mackenzie-Graham AJ, Merrill JE (1994) The role of nitric oxide in glial pathology. Ann NY Acad Sci 738:436-446
116. Johnson AW, Land JM, Thompson EJ, Bolanos JP, Clark JB, Heales SJR (1995) Letters to the editor. J Neurol Neurosurg Psychiatry 58:107-115
117. Boullerne AI, Petry KG, Meynard M, Geffard M (1995) Indirect evidence for nitric oxide involvment in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrocysteine. J Neuroimmunol 60:117-124
118. Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadeval A, Lee S, C (1994) Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 16:152-161
119. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains 36:778-786
120. Mitrovic B, Parkinson JF, Merrill JE (1996) An in vitro model of oligodendrocyte destruction by nitric oxide and its relevance to multiple sclerosis. Methods, A companion to methods in Enzymology, vol 10
121. Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF, Tawadros R, Koprowski H (1996) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. 92:12041-12045
122. Agullo L, Garcia A (1992) Different receptors mediate stimulation of nitric oxide-dependent cyclic GMP formation in neurons and astrocytes in culture. Biochem Biophys Res Commun 182:1362-1368
123. Baltrons MA, Agullo L, Garcia A (1995) Dexamethasone upregulates a constitutive nitric oxide synthase in cerebellar astrocytes but not in granule cells in culture. J Neurochem 654: 447-450
124. Simmons ML, Murphy S (1992) Induction of nitric oxide synthase in glial cells. J Neurochem 59:897-905
125. Galea E, Feinstein DL, Reis DJ (1992) Induction of calcium-independent nitricoxide synthase activity in primary rat glial cultures. Proc Natl Acad Sci USA 89:10945-10949
126. Galea E, Reis DJ, Feinstein DL (1994) Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J Neurosci Res 37:406-414
127. Bolano JP, Peuchen S, Heales SJ, Land M, Clark JB (1994) Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J Neurochem 63:910-916
128. Dawson VL, Brahmbhatt HP, Mong JA, Dawson TM (1994) expression of inducible nitric oxide synthase causes delayed neurotoxicity in prmary mixed neuronal-glial cortical cultures. Neuropharmacol 33:1425-1430
129. Bernatowicz A, Kodel U, Frei K, Fontana A, Pfister HW (1995) Production of nitrite by primary rat astrocytes in response to pneumococci. J Neuroimmunol 60:53-61
130. Hu J, Castets F, Guevara JL, Vun-eldik L J (1996) S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J Biol Chem 271:2543-2547
131. Boje KM, Arora PK (1992) Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 587:250-256
132. Sakai N, Kaufman S, Milstien S (1995) Parallel induction of nitric oxide amd tetrahydrobiopterin synthesis by cytokines in rat glial cells. J Neurochem 65:895-902
133. Goodwill JL, Uemera E, Cunnick JE (1995) Microglial release of nitric oxide by the synergisit action of beta-amyloid and IFN-γ. Brain Res 692:207-214
134. Simmons ML, Murphy S (1993) Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur J Neurosci 5:825-831
135. Feinsten DL, Galea E, Roberts S, Berquist H, Wang H, Reis DJ (1994) Induction of nitric oxide synthase in rat C6 glioma cells. J Neurochem 62:315-321
136. Feinsten DL, Galea E, Cermak J, Chugh P, Lyandvert L, Reis DJ (1994) Nitric oxide synthase expression in glial cells: suppression by tyrosine kinase inhibitors. J Neurochem 62: 811-814
137. Park SK, Murphy S (1994) Duration of inducible nitric oxide synthase in glial cells. J Neurosci Res 39:405-411
138. Hewett SJ, Corbett JA, McDaniel ML, Choi DW (1993) Interferon-γ and interleukin-1b induce nitric oxide formation from primary mouse astrocytes. Neurosci Lett 164:229-232
139. Hewett SJ, Csernansky CA, Choi DW (1994) Selective potentiation of NMDA-induced neuronal injury folowing induction of astrocytic i-NOS. Neuron 13:487-494
140. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK (1992) Activated microglia mediate neuronal injury via a nitric oxide mechanism. J Immunol 149:2736-2741
141. Chao CC, Anderson WR, Hu S, Gekker G, Martella A, Peterson PK (1993) Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin Immunol Immunopathol 67:178-183
142. Peterson PK, Hu S, Anderson WR, Chao CC (1994) Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain J Infect Dis 170: 457-460
143. Corradin SB, Mauel J, Donini SD, Quattrocchi E, Ricciardi-Castagnoli P (1993) Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia 7:255-263
144. Colasanti M, Persechini T, Di-Pucchio T, Gremo F, Lauro GM (1995) Human ramified microglial cells produce nitric oxide upon Escherichia coli lipopolysacharide and tumor necrosis factor alpha stimulation. Neurosci Lett 200:144-146
145. Colasanti M, Persechini T, Menegazzi M, Mariotto S, Giordano E, Caldarera CM, Sogos V, Luaro GM, Suzuki H (1995) Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J Biol Chem 270: 26731-26733
146. Colasanti M, Mollace V, Cundari E, Massoud R, Nistico G, Lauro GM (1993) Int J Immunopharmacol 15:763-771
147. Mollace V, Colasanti M, Rodino P, Lauro GM, Rotiroti D, Nistico G (1995) NMDA-dependent prostaglandin E2 release by cultured human astroglial cells is driven by nitric oxide. Biochem Biophys Res Commun 215:793-799
148. Hokari A, Zeniya M, Esumi H (1994) Cloning and functional expression of human inducible nitric oxide synthase (NOS) cDNA from a glioblastoma cell line A-172. J Biochem Tokyo 116:575-581
149. Fujisawa H, Ogura T, Hokari A, Weisz A, Yamashita J, Esumi H (1995) Inducible nitric oxide synthase in a human glioblastoma cell line. J Neurochem 64:85-91